迄今哮喘仍无有效的病因疗法,对症治疗是主要的治疗手段。目前比较有效的药物有气道扩张药(β_2受体激动剂、茶碱类、抗胆碱药)、过敏介质阻释药及糖皮质激素,已涌现大批高效、长效制剂。但单用一种药物常不能有效地控制病情,且不良反应较重,联合用药可提高疗效、减少用药剂量、减少或减轻不良反应。近年来,关于平喘药联合应用有大量报告,现加综合介绍,供临床用药参考。 So far there is no effective etiology of asthma therapy, symptomatic treatment is the main treatment. Currently more effective drugs have airway dilatation drugs (β 2 receptor agonists, theophylline, anticholinergic drugs), allergic mediators and glucocorticoid drugs, has emerged a large number of high-efficient, long-acting preparations. However, a single drug often can not effectively control the disease, and adverse reactions, combined treatment can improve the efficacy, reduce the dosage, reduce or reduce adverse reactions. In recent years, the joint application of antiasthmatic drugs have a large number of reports, plus a comprehensive introduction for clinical reference.